Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
4.540
-0.240 (-5.02%)
May 21, 2026, 3:04 PM CST
SHE:002581 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 153.86 | 220.25 | 506.4 | 151.91 | 183.8 | 187.8 |
Trading Asset Securities | 0.02 | 0.02 | - | - | - | - |
Cash & Short-Term Investments | 153.88 | 220.27 | 506.4 | 151.91 | 183.8 | 187.8 |
Cash Growth | -65.42% | -56.50% | 233.35% | -17.35% | -2.13% | -33.91% |
Accounts Receivable | 253.81 | 279.66 | 93.32 | 172.62 | 179.72 | 272.96 |
Other Receivables | 9.12 | 12.05 | 52.24 | 78.87 | 18.36 | 13.49 |
Receivables | 262.93 | 291.72 | 145.55 | 251.49 | 198.09 | 286.45 |
Inventory | 116.82 | 93.25 | 79.64 | 85.31 | 80.04 | 64.33 |
Other Current Assets | 22.37 | 24.1 | 15.41 | 7.99 | 56.43 | 29.88 |
Total Current Assets | 556 | 629.34 | 747.01 | 496.71 | 518.36 | 568.45 |
Property, Plant & Equipment | 351.08 | 350.09 | 274.74 | 357.84 | 705.47 | 713.76 |
Long-Term Investments | 922.78 | 938.34 | 1,056 | 1,355 | 1,503 | 1,223 |
Other Intangible Assets | 89.04 | 90.81 | 93.47 | 108.29 | 126.32 | 134.29 |
Long-Term Deferred Tax Assets | 27.69 | 27.32 | 11.21 | 6.12 | 11.84 | 25.28 |
Long-Term Deferred Charges | 15.63 | 9.73 | 0.32 | 1.41 | 5.2 | 7.78 |
Other Long-Term Assets | 127.63 | 122.74 | 13.44 | 12.26 | 0.49 | 83.36 |
Total Assets | 2,090 | 2,168 | 2,196 | 2,337 | 2,870 | 2,756 |
Accounts Payable | 77.83 | 88.39 | 35.35 | 73.69 | 43.64 | 42.13 |
Accrued Expenses | 7.42 | 13.34 | 20.83 | 22.5 | 19.32 | 31.01 |
Short-Term Debt | 27.5 | 32.53 | 2.77 | 13.84 | 150.42 | 151.54 |
Current Portion of Long-Term Debt | 16.58 | 17.72 | - | - | - | - |
Current Portion of Leases | - | - | 0.17 | - | 13.46 | 15.83 |
Current Income Taxes Payable | 1.32 | 4.22 | - | 0.95 | 1.2 | 0.44 |
Current Unearned Revenue | 2.47 | 2.92 | 10.46 | 3.59 | 26.86 | 3.43 |
Other Current Liabilities | 19.03 | 31.66 | 13.03 | 19.03 | 109.38 | 14.17 |
Total Current Liabilities | 152.17 | 190.78 | 82.61 | 133.61 | 364.28 | 258.54 |
Long-Term Debt | 10 | 8.5 | - | - | - | - |
Long-Term Leases | 3.52 | 2.69 | - | 0.71 | 1.47 | 9.8 |
Long-Term Unearned Revenue | 5.49 | 5.49 | 5.49 | 5.49 | 6.71 | 9.74 |
Long-Term Deferred Tax Liabilities | 9.66 | 9.59 | 9.39 | 7.51 | 7.68 | 8.68 |
Other Long-Term Liabilities | 4.93 | 4.94 | 76.12 | 16.09 | 9.67 | - |
Total Liabilities | 185.78 | 222 | 173.61 | 163.41 | 389.82 | 286.76 |
Common Stock | 229.15 | 229.15 | 229.15 | 229.15 | 229.15 | 229.15 |
Additional Paid-In Capital | 917.16 | 901.28 | 866.41 | 873.93 | 858.5 | 858.29 |
Retained Earnings | 657.57 | 711.79 | 828.08 | 965.39 | 1,298 | 1,301 |
Total Common Equity | 1,804 | 1,842 | 1,924 | 2,068 | 2,385 | 2,388 |
Minority Interest | 100.2 | 104.16 | 98.67 | 105.26 | 94.94 | 81.11 |
Shareholders' Equity | 1,904 | 1,946 | 2,022 | 2,174 | 2,480 | 2,469 |
Total Liabilities & Equity | 2,090 | 2,168 | 2,196 | 2,337 | 2,870 | 2,756 |
Total Debt | 57.61 | 61.43 | 2.94 | 14.55 | 165.35 | 177.16 |
Net Cash (Debt) | 96.27 | 158.84 | 503.47 | 137.36 | 18.45 | 10.64 |
Net Cash Growth | -78.05% | -68.45% | 266.52% | 644.38% | 73.50% | -90.91% |
Net Cash Per Share | 0.15 | 0.24 | 0.76 | 0.21 | 0.03 | 0.02 |
Filing Date Shares Outstanding | 659.68 | 659.1 | 659.74 | 659.74 | 659.74 | 659.74 |
Total Common Shares Outstanding | 659.68 | 659.1 | 659.74 | 659.74 | 659.74 | 659.74 |
Working Capital | 403.83 | 438.56 | 664.4 | 363.1 | 154.08 | 309.91 |
Book Value Per Share | 2.73 | 2.80 | 2.92 | 3.14 | 3.62 | 3.62 |
Tangible Book Value | 1,715 | 1,751 | 1,830 | 1,960 | 2,259 | 2,254 |
Tangible Book Value Per Share | 2.60 | 2.66 | 2.77 | 2.97 | 3.42 | 3.42 |
Buildings | - | - | 393.55 | 486.08 | 639.62 | 612.92 |
Machinery | - | - | 431.4 | 432.25 | 413.16 | 424.47 |
Construction In Progress | - | - | 38.11 | 22.17 | 91.43 | 64.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.